APRN Blows its Lid & More

Blue Apron Holdings Inc. APRN

We provided readers with a set of stocks that we felt were uniquely built to weather the coronavirus storm in yesterday morning’s premarket report. APRN had already begun to rise a little bit prior to that, but yesterday’s huge session really sent it for a ride.

The stock registered as the number three top gainer on the NASDAQ for its performance, which saw it trade up from a low 8.70 and hit 19.49, which represents an intraday rise of 124%. As of this morning’s premarket trading, APRN has now hit 24.50, extending our total observed range in 24 hours to 182%

With people being urged to stay home as much as possible, and perhaps with a mandatory nationwide quarantine on the way, we would expect Blue Apron’s order volume to stay at what we can only imagine are all time highs. As far as how high the stock could run, that’s anyone’s guess, but we’ll be tracking it closely to find out.

Decision Diagnostics Corp. DECN

Certain stocks on the OTC have also been enjoying solid performances in relation to the coronavirus.  The company believes that its GenViro! COVID-19 “Rapid” Kit will be in high demand after the release of new FDA guidance allowing for near immediate distribution of kits with minimal red tape.

We had placed the stock in our extended watchlist in yesterday morning’s report, and were met with a very respectable intraday move from .118-.198, which works out to a gain of 68%

Fresh Options Ideas

GILD Weekly $79-81 Calls
WBA Weekly $52.50-54 Calls
HAL 04/03 $4-5.00 Calls 

Coronavirus Watchlist & More

Todos Medical, Ltd. TOMDF

The see-saw of market volatility persists with no end in sight. Traditional investing has become a fool’s errand in many, if not most, cases. The kind of opportunistic short term trading that we do is relatively intact, with the right targets and scenarios.

In this case, we caught TOMDF’s coronavirus news in the premarket yesterday, stating that the company had secured distribution agreements for testing kits in both the US and Isreal. After including it in our extended watchlist, the stock managed a very nice intraday gain. It traded up from a low of  0413, and reached a high of .08, which works out to an intraday upswing of 94%

Coronavirus Watchlist

While we do focus primarily on quick strike opportunities, it’s also worth it to mention a few plays that represent products and services that are high demand at the present time due to the fallout from COVID-19. If the report from the UK’s highly respected Imperial College is accurate, this global health crisis is only in its beginning stages, and will get much, much worse in the months ahead.

While neither these, nor any other plays are “corona-proof”, the effects may weigh less heavily on these stocks and those like them:


Extended Watchlist:

Blue Horseshoe Stocks: Bottom Watch Plays

Activision Blizzard, Inc. ATVI

Despite beating on earnings in its postmarket release yesterday afternoon, ATVI reported fewer monthly active subscribers, and the stock has taken a gut punch as a result, falling to new annual lows in the mid-$50’s. The stock hasn’t seen a PPS this low since last December, and it went on to have a post-holiday run into March of this year, and yet another in the spring.

While we don’t expect an exact repeat of history, at present the stock is highly oversold, and we want to set up a longer-term recovery play to place on watch today and monitor going forward. We’ll be looking at the ATVI 01/18 $55-62.50 Calls for this purpose.

Bunge Ltd. BG

We’ve also taken notice of an interesting setup on BG, which has been recently trading at a double bottom, and whose CEO just picked up nearly a hundred million dollars worth of the stock here at these lows. He was also joined by another insider which submitted a pair of Form-4’s for the purchase of roughly $40M.

That’s an incredibly large bet on the part of the company’s leader, far out of the realm of simply trying to prop up his company’s stock. To invest that kind of money, would seem to imply a firm inside belief that BG won’t go much lower than what we’ve seen in the past week or so. We’ll place this stock on a Form-4 Bottom Watch moving forward, and monitor for the possibility of a nice rebound.

Extended Watchlist: